Finance

Lists
Why is ARTV down 2.86%?
Dive Deeper
ARTV:NASDAQ
Artiva Biotherapeutics Inc
$6.80
-2.86%
(-0.20) 1D
$6.80
0.00% (0.00)
After hours
Closed: Oct 8, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ARTV...
Open
$6.89
High
$6.92
Low
$6.58
Mkt. cap
332.45M
Avg. vol.
451.68K
Volume
339.39K
52-wk high
$14.53
52-wk low
$2.71
EPS
-$3.31
Shares outstanding
48.89M
No. of employees
115
Open
$6.89
High
$6.92
Low
$6.58
Mkt. cap
332.45M
Avg. vol.
451.68K
Volume
339.39K
52-wk high
$14.53
52-wk low
$2.71
EPS
-$3.31
Shares outstanding
48.89M
No. of employees
115
News stories
From web sources and news partners
About Artiva Biotherapeutics Inc
CEO-
Employees115
Founded2019
Headquarters-
SectorBiotechnology
Websiteartivabio.com
Analyst ratings
Based on 3 analysts giving stock ratings to ARTV in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for ARTV in the last 3 months.
Highest
Current $6.80
$41.00 (+502.94%)
Average
$38.00 (+458.82%)
Lowest
$35.00 (+414.71%)
Analyst
Recommendation
Action
Price target
Projected
Date
Gil Blum
Needham
Buy
Maintained
$41.00
+502.9%
10/01/2026
Emily Bodnar
H.C. Wainwright
Buy
Maintained
$35.00
+414.7%
10/01/2026
Tyler Van Buren
TD Cowen
Buy
Maintained
-
-
08/07/2026
Joshua Schimmer
Cantor Fitzgerald
Buy
Maintained
$40.00
+488.2%
05/25/2026
Unknown Analyst
Jefferies
Buy
Maintained
$23.00
+238.2%
05/21/2026
Martin Fan
Wedbush
Buy
Maintained
$40.00
+488.2%
05/21/2026
David Nierengarten
Wedbush
Buy
Maintained
$40.00
+488.2%
05/21/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
17.63M
16.99M
19.31M
21.92M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.26M
4.94M
5.12M
4.96M
Operating expense
22.90M
21.93M
24.43M
26.89M
Total operating expenses
22.90M
21.93M
24.43M
26.89M
Operating income
-22.90M
-21.93M
-24.43M
-26.89M
Other non operating income
-3.00K
-1.88M
2.00K
-1.00K
EBT including unusual items
-21.53M
-20.77M
-23.52M
-25.00M
EBT excluding unusual items
-21.53M
-22.65M
-23.52M
-25.00M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-21.53M
-20.77M
-23.52M
-25.00M
Net profit margin
-
-
-
-
Earnings per share
-0.88
-0.84
-0.95
-0.63
Interest and investment income
1.37M
1.16M
912.00K
1.89M
Interest expense
-
-
-
-
Net interest expenses
1.37M
1.16M
912.00K
1.89M
Depreciation and amortization charges
-
-
-
-
EBITDA
-22.24M
-21.27M
-23.76M
-26.20M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps